Non-Coding RNAPub Date : 2026-10-20DOI: 10.3390/ncrna12050042
Elena V Mikheeva, Galina S Chicherina, Kseniya S Aulova, Georgy A Nevinsky, Anna M Timofeeva
{"title":"Tissue-Specific miRNA Responses to Tick-Borne Encephalitis Virus Strains in Mice.","authors":"Elena V Mikheeva, Galina S Chicherina, Kseniya S Aulova, Georgy A Nevinsky, Anna M Timofeeva","doi":"10.3390/ncrna12050042","DOIUrl":"10.3390/ncrna12050042","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Tick-borne encephalitis virus (TBEV) is a vector-borne flavivirus that targets the CNS and causes severe encephalitis with long-term neurological sequelae. As the geographic range of its vectors expands and climate conditions shift, the incidence of tick-borne encephalitis continues to rise, yet no specific antiviral therapy has been developed to date. Understanding the molecular mechanisms of tissue-specific immune responses during TBEV infection is essential for identifying novel therapeutic targets and biomarkers. <b>Methods</b>: In this study, quantitative reverse transcription PCR with stem-loop primers was used to examine changes in the levels of seven immunoregulatory miRNAs (let-7i, miR-9-5p, miR-21a-5p, miR-30a-5p, miR-146b-5p, miR-181a-5p, miR-486-5p) in blood plasma, peripheral organs (spleen, liver), and four central nervous system structures (olfactory bulb, cerebral hemispheres, cerebellum, spinal cord) of BALB/c mice. Three experimental groups were compared: (1) infection with the Aina strain (Siberian subtype), (2) infection with the Sofyin strain (Far Eastern subtype), and (3) vaccination with the vaccine \"Tick-E-Vak\". <b>Results</b>: It was shown that both infection and vaccination induce pronounced tissue-specific changes in the miRNA profile. MiR-181a-5p is a negative regulator of TLR4/NF-κB signaling. Its downregulation was the most reproducible change observed across all compartments and in all three groups, suggesting a possible universal mechanism for derepression of the proinflammatory cascade. Two miRNAs (miR-30a-5p and miR-146b-5p) were altered in all examined tissues and may be considered candidate markers of antigenic stimulation. <b>Conclusions</b>: The direction of their changes in plasma and tissues was frequently opposite, suggesting redistribution of miRNAs between the tissue and circulating pools, which is important for the interpretation of plasma biomarkers. Infection-specific changes were identified for let-7i and miR-9-5p in the CNS. The most pronounced changes were observed in the structures most affected by neuroinvasion (olfactory bulb, spinal cord), making them candidate markers associated with TBEV infection and CNS involvement. Infection with the Aina strain induced more pronounced miRNA changes in peripheral organs and the CNS than the Sofyin strain, despite the higher epidemiological lethality of the latter. This suggests that the pathogenicity of individual strains in the mouse model may not always correspond to the subtype-based lethality classification in humans and is determined by strain-specific features of tropism and infection kinetics.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13708369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149271361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-10-19DOI: 10.3390/ncrna12050041
Andrea Bakó, Bernadett Torner, Dóra Géczi, András Penyige, Péter Pozsgai, Zsuzsanna Birkó, Álmos Klekner
{"title":"Identification of Survival-Associated miRNA Signatures in Glioblastoma Using Next-Generation Sequencing.","authors":"Andrea Bakó, Bernadett Torner, Dóra Géczi, András Penyige, Péter Pozsgai, Zsuzsanna Birkó, Álmos Klekner","doi":"10.3390/ncrna12050041","DOIUrl":"10.3390/ncrna12050041","url":null,"abstract":"<p><p><b>Background:</b> Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and is characterized by pronounced molecular heterogeneity, contributing to poor prognosis and limited therapeutic responsiveness. Distinct clinical subgroups, including short-term survivors (GBM-STS) and long-term survivors (GBM-LTS), differ substantially in disease progression and outcome; however, reliable biomarkers for prognostic stratification remain insufficiently defined. This study aimed to identify microRNA (miRNA) expression patterns capable of distinguishing GBM-STS from GBM-LTS patients. <b>Methods:</b> miRNA expression profiling was performed on glioblastoma tissue samples using next-generation sequencing (NGS). Differentially expressed miRNAs between GBM-STS and GBM-LTS groups were subjected to Gene Ontology (GO) Biological Process enrichment analysis to identify dysregulated pathways associated with their predicted target genes. Selected candidate miRNAs were further validated by reverse transcription quantitative polymerase chain reaction (RT-qPCR). <b>Results:</b> Functional enrichment analysis revealed significant overrepresentation of pathways related to neurogenesis, neuronal differentiation, and neuron projection development, supporting the involvement of neural developmental programs in glioblastoma progression and invasion. NGS and RT-qPCR analyses demonstrated significant downregulation of hsa-miR-133a-3p, and significant upregulation of hsa-miR-424-5p and has-miR-216a-5p in GBM-STS tissues compared with GBM-LTS and control samples. <b>Conclusions:</b> Our findings demonstrate that distinct miRNA expression profiles are associated with survival-related glioblastoma subgroups and may contribute to differences in tumor aggressiveness. Hsa-miR-424-5p, has-miR-216a-5p, and hsamiR-133a-3p may represent promising candidate biomarkers for prognostic stratification in glioblastoma.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13708145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149271301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From Binding Sites to Target Genes: Reframing Human microRNA Target Prediction.","authors":"Stephanie Sammut, Elissavet Zacharopoulou, Dimosthenis Tzimotoudis, Panagiotis Alexiou","doi":"10.3390/ncrna12050040","DOIUrl":"10.3390/ncrna12050040","url":null,"abstract":"<p><p>MicroRNA (miRNA) target prediction is often treated as a single problem, yet it encompasses two distinct computational tasks: identifying whether a miRNA can bind a particular target RNA binding site, and predicting the change in gene expression that follows from miRNA perturbation. Here, we trace the evolution of the field of miRNA target prediction in humans from early seed- and conservation-based algorithms, to deep learning models trained on large-scale interaction datasets. We note that early frameworks obscured binding site recognition and gene-level regulation by aggregating binding site-level scores into gene-level predictions, whereas newer experimental and computational advances have enabled a clearer separation of the tasks. Deep learning has substantially advanced miRNA binding site prediction, but progress in miRNA target gene prediction remains constrained by limited perturbation data, inconsistent data processing and annotations, heterogeneous definitions of regulatory response, uneven predictor coverage, and the absence of comprehensive benchmarks. We also highlight the importance of negative-example construction, which can introduce dataset-specific biases and inflate apparent model performance. We propose two complementary benchmarked community challenges: the prediction of miRNA-binding site interactions, and the genome-wide prediction of miRNA-mediated changes in target gene expression in defined biological contexts. Treating these as distinct computational tasks, while recognising their biological interdependence, would enable more meaningful evaluation of methodological advances and provide a stronger foundation for modelling miRNA-mediated regulatory networks.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13708510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149271363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-10-13DOI: 10.3390/ncrna12050039
Zhangchi Xu, Rong Pan, Tianzhou Ma
{"title":"CQRM: A Composite Quantile Regression Model for Differential Expression Analysis of Non-Coding RNA Count Data.","authors":"Zhangchi Xu, Rong Pan, Tianzhou Ma","doi":"10.3390/ncrna12050039","DOIUrl":"10.3390/ncrna12050039","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Non-coding RNAs (ncRNAs) play important roles in various biological processes, primarily via regulating gene expression at multiple levels. Nevertheless, compared to protein-coding genes, ncRNAs are relatively understudied. They are characterized by low expression, large variation, and more dynamic expression across different tissues and cell types, which creates unique challenges in differential expression (DE) analysis. <b>Methods:</b> We propose the CQRM, an adaptive multi-quantile testing framework for ncRNA count data that incorporates jittering to accommodate discrete counts, combines dependent evidence across quantiles, and selects the most informative quantile subset for distinguishing conditions. <b>Results:</b> The CQRM captures diverse expression differences, including changes in variability, skewness, and modality beyond mean shifts. Model-based simulations showed that the CQRM improved the detection of differentially expressed ncRNAs while controlling the false discovery rate relative to existing DE tools, especially when DE genes exhibited multimodal expression patterns and counts were low. Critical ncRNAs and biologically interpretable targeted pathways were identified when we further applied our method to a Smart-seq-total single-cell RNA-seq dataset and a human organ developmental RNA-seq dataset. <b>Conclusions:</b> CQRM complements mean-based DE methods by capturing heterogeneous ncRNA expression changes, supporting the identification of candidate ncRNA biomarkers and regulatory processes relevant to development and disease.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13708692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149271339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-09-28DOI: 10.3390/ncrna12050038
Jane L Zen, Quynh Mai Nguyen Le, Shizhou Li, George B Hanna
{"title":"Skin-Derived Non-Coding RNAs as Potential Biomarkers and Therapeutic Targets.","authors":"Jane L Zen, Quynh Mai Nguyen Le, Shizhou Li, George B Hanna","doi":"10.3390/ncrna12050038","DOIUrl":"10.3390/ncrna12050038","url":null,"abstract":"<p><p>Skin-derived extracellular nucleic acids-particularly non-coding RNAs (ncRNAs) such as miRNAs and lncRNAs-are a rapidly evolving frontier in molecular diagnostics. These molecules are present in skin tissue, dermal interstitial fluid, and sweat, whilst ncRNAs regulate essential processes including epidermal differentiation, wound healing, immune regulation, and tumourigenesis, positioning them as promising candidates for minimally invasive biomarker development across a broad spectrum of dermatological diseases. This narrative review summarises their biological functions and potential clinical applications. The available evidence provides a conceptual basis for an emerging cutaneous \"surface liquid biopsy\" framework, whilst highlighting the need for standardised sampling, analytical validation, and clinical evaluation before such approaches can be translated into clinical practice. Although ample disease-associated ncRNA signatures have been uncovered, many remain at exploratory or early translational stages, and the concordance of these ncRNA signatures with corresponding blood and tissue biomarkers needs to be established. Continued advances in sampling strategies, analytical technologies, and clinical validation are needed to translate these findings into clinically deployable platforms for dermatological diseases and, potentially, systemic diseases in the future.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13708295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149271337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-09-15DOI: 10.3390/ncrna12050037
Min S Kwon, Hee K Chung, Hongxia Chen, Amy VanderStoep, Bridgette Warner, Haonan Zhao, Prathik Atluri, Emnet Tesfayohannes, Douglas J Turner, Lan Xiao, Jian-Ying Wang
{"title":"Long Noncoding RNA <i>H19</i> Inhibits Differentiation and Function of Secretory Lineage Cells in the Intestinal Epithelium by Targeting ATOH1.","authors":"Min S Kwon, Hee K Chung, Hongxia Chen, Amy VanderStoep, Bridgette Warner, Haonan Zhao, Prathik Atluri, Emnet Tesfayohannes, Douglas J Turner, Lan Xiao, Jian-Ying Wang","doi":"10.3390/ncrna12050037","DOIUrl":"10.3390/ncrna12050037","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Intestinal mucosal function relies on the integrated contribution of multiple cell lineages, including secretory cells. Long noncoding RNA <i>H19</i> modulates many cell processes essential for human pathologies. Here, we investigated the role of <i>H19</i> in development and function of secretory lineage cells and elucidated the implication of altered ATOH1 by <i>H19</i> in dysfunction of the secretory cells. <b>Methods</b>: Studies were conducted in <i>H19</i>-transgenic (H19-Tg) and <i>H19</i>-knockout (H19<sup>-/-</sup>) mice, intestinal organoids, and Caco-2 cells. Secretory lineage cells were examined by fluorescent immunostaining with their specific cell markers, including Lysozyme, Mucin2, DCLK1, and Chromogranin A. Intestinal mucosal growth was measured by BrdU incorporation, and intestinal permeability was detected by paracellular tracer flux assay using FITC-Dextran. Single cell RNA-sequence, quantitative real-time PCR, and Western immunoblotting analyses were used to monitor changes in gene expression. <b>Results</b>: Tissue-specific transgenic expression of <i>H19</i> in the intestinal epithelium caused defects in Paneth, goblet, tuft, and enteroendocrine cells in mice, whereas targeted deletion of the <i>H19</i> gene increased the function of secretory lineage cells. Locally increasing the levels of <i>H19</i> in the epithelium impaired gut barrier function in H19-Tg mice, although it failed to alter mucosal growth. The intestinal mucosal tissues of H19-Tg mice exhibited a remarkable decrease in the levels of differentiation-associated transcription factors including ATOH1. Ectopically expressed ATOH1 in the <i>H19</i>-enriched intestinal organoids derived from H19-Tg mice rescued development of the secretory lineage cells. Mechanistically, <i>H19</i> inhibited ATOH1 expression via inhibition of its translation. <b>Conclusions</b>: These findings indicate that <i>H19</i> functions as a negative regulator of differentiation and function of secretory lineage cells in the intestinal mucosa at least partially via the inhibition of ATOH1 translation.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13600228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-09-07DOI: 10.3390/ncrna12050036
Minseon Kim, Seung-Kyoon Kim, Jaeil Han
{"title":"A Transcriptome-Wide Analysis Nominates DIO3OS and C9orf139 as Survival-Associated Long Non-Coding RNAs in Glioblastoma.","authors":"Minseon Kim, Seung-Kyoon Kim, Jaeil Han","doi":"10.3390/ncrna12050036","DOIUrl":"10.3390/ncrna12050036","url":null,"abstract":"<p><p><b>Background</b>: Long non-coding RNAs (lncRNAs) are widely proposed as determinants of temozolomide response in glioblastoma (GBM), but many nominations rest on analyst-derived survival endpoints, screens unadjusted for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and models evaluated with the same data used to select them. We asked which lncRNA-outcome associations remain when endpoint definition, confounder adjustment, and external validation are addressed explicitly. <b>Methods</b>: We analyzed 94 IDH-wildtype, temozolomide-treated primary GBM patients from The Cancer Genome Atlas (TCGA), using the rule-based progression-free interval (PFI) of the TCGA Pan-Cancer Clinical Data Resource and overall survival (OS) as separate endpoints. A joint transcriptome-wide discovery for OS was performed across TCGA and the identically processed CPTAC-3 cohort (n = 282, 209 deaths), the latter unselected for IDH status because IDH annotation is unavailable for CPTAC-3, with adjustment for MGMT promoter methylation status, cellular composition, and expression subtype. Nominated transcripts were tested for external validation in two independent CGGA cohorts, and incremental discrimination was assessed as the optimism-corrected change in C-index (ΔC-index), benchmarked against the gain expected from a transcriptome-wide search alone. <b>Results</b>: No lncRNA was associated with PFI at a transcriptome-wide false-discovery rate (FDR) below 0.05. The joint OS discovery nominated DIO3OS, the only transcript reaching transcriptome-wide significance (hazard ratio 1.38 per standard deviation, 95% confidence interval 1.20-1.58, FDR 0.022), and C9orf139 (FDR 0.065); both were independently significant in each discovery cohort and robust to adjustment for MGMT status, cellular composition, and expression subtype. Both, however, were null with reversed point estimates in the two CGGA cohorts, were unassociated with PFI, and added only modest optimism-corrected discrimination (ΔC-index 0.07-0.11), close to what a transcriptome-wide search alone generates. Replication was thus confined to two cohorts sharing a processing pipeline. <b>Conclusions</b>: We nominate DIO3OS and C9orf139 as candidate survival-associated lncRNAs in GBM, requiring prospective evaluation in cohorts with complete IDH annotation and progression endpoints, and show how endpoint definition, selection optimism, and external validation determine which lncRNA associations survive scrutiny.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13600001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-09-01DOI: 10.3390/ncrna12050034
Ezgi Biltekin, Bulent Ozpolat
{"title":"microRNAs as Regulators of the Immune Response and Their Potential Therapeutic Applications in Cancer.","authors":"Ezgi Biltekin, Bulent Ozpolat","doi":"10.3390/ncrna12050034","DOIUrl":"10.3390/ncrna12050034","url":null,"abstract":"<p><p>MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as critical regulators of gene expression and key cellular processes in cancer, including tumor cell proliferation, survival, metastasis, and both innate and adaptive immune responses within the tumor microenvironment. Through their ability to modulate immune cell development, differentiation, polarization, antigen presentation, cytokine signaling and immune checkpoint expression, miRNAs play a vital role in shaping immune responses and represent attractive therapeutic candidates for remodeling the tumor immune microenvironment. This review provides a comprehensive overview of the mechanisms through which miRNAs regulate anti-tumor immunity and contribute to immune evasion with particular emphasis on their role in modulating major immune checkpoint pathways, including PD-1/PD-L1, CTLA-4, LAG-3, TIM-3 and CD28-mediated signaling. We further examine the contribution of miRNAs to therapeutic resistance and discuss their potential integration with immune checkpoint blockade, chemotherapy, PARP inhibitors and targeted therapies to enhance antitumor efficacy and overcome treatment resistance. Recent advances in spatial transcriptomics and computational approaches have expanded our understanding of miRNA-mediated regulatory networks at single-cell and tissue levels and provide new insights into tumor-immune interactions. In addition, we evaluate the current progress in the clinical development of miRNA-based therapeutics, including miRNA mimics and inhibitors and discuss the major challenges associated with efficient delivery, off-target effects, immunogenicity and patient heterogeneity. Collectively, the evidence highlights the growing potential of miRNAs as diagnostic biomarkers, therapeutic targets and therapeutic tools in cancer immunotherapy. Continued advances in RNA therapeutics, delivery technologies and multi-omics approaches are expected to accelerate the clinical translation of miRNA-based strategies for personalized cancer therapy.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13600176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-09-01DOI: 10.3390/ncrna12050035
Małgorzata Litwiniuk-Kosmala, Maria Makuszewska, Robert Bartoszewicz, Agnieszka Jasińska-Nowacka, Maciej Ołdak, Bartłomiej Gielniewski, Bartosz Wojtaś, Kazimierz Niemczyk
{"title":"Cerebrospinal Fluid miRNA Profiling as a Potential Liquid Biopsy for Vestibular Schwannomas.","authors":"Małgorzata Litwiniuk-Kosmala, Maria Makuszewska, Robert Bartoszewicz, Agnieszka Jasińska-Nowacka, Maciej Ołdak, Bartłomiej Gielniewski, Bartosz Wojtaś, Kazimierz Niemczyk","doi":"10.3390/ncrna12050035","DOIUrl":"10.3390/ncrna12050035","url":null,"abstract":"<p><p><b>Background/Objectives</b>: This study aimed to identify a characteristic miRNA expression profile in the CSF of patients diagnosed with vestibular schwannoma and evaluate its potential for tumor assessment. <b>Methods</b>: In this prospective study, 17 CSF and corresponding tumor samples (seven small tumors-SVS and 10 large tumors-LVS) were collected from patients operated on for VS in a Tertiary Academic Center. The miRNA expression was analyzed using high-throughput RNA sequencing (NovaSeq 6000 Illumina). Data were normalized, and a comparative analysis of miRNA expression rankings was performed between VS patients and a public healthy donor dataset. Functional implications were explored using KEGG pathway enrichment analysis. <b>Results</b>: A total of 1633 miRNAs were identified in all CSF samples derived from VS patients. Comparison with healthy donors revealed a moderate ranking correlation (ρ = 0.39), with significant shifts for specific molecules like hsa-miR-766-3p and hsa-miR-182-5p. Only six miRNAs were found to correlate between CSF and tumor tissue, while 16 exhibited a negative correlation. No statistical correlation was found between tumor size and the CSF miRNA profile. KEGG analysis highlighted enriched pathways, including neurotrophin signaling and focal adhesion. <b>Conclusions</b>: The results of our study support the feasibility of miRNA-based CSF liquid biopsy for VS assessment. However, the results of miRNA expression profiling conducted in tumor tissue cannot be directly transferred into CSF sample analyses. Further studies are warranted to explain this phenomenon and to search for reliable miRNA markers of VS progression in the CSF liquid biopsy specimens.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13600145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Non-Coding RNAPub Date : 2026-08-30DOI: 10.3390/ncrna12050033
Monyse Nobrega, Hellen Kuasne, Marilesia Ferreira de Souza, Mariana Bisarro Dos Reis, Larissa Cristina Bastos de Oliveira, Paulo Emilio Fuganti, Morag Park, Ilce Mara de Syllos Cólus
{"title":"Circulating Cell-Free miR-25-3p Is Upregulated in Brazilian Patients with Prostate Cancer and Contributes to Tumor Aggressiveness.","authors":"Monyse Nobrega, Hellen Kuasne, Marilesia Ferreira de Souza, Mariana Bisarro Dos Reis, Larissa Cristina Bastos de Oliveira, Paulo Emilio Fuganti, Morag Park, Ilce Mara de Syllos Cólus","doi":"10.3390/ncrna12050033","DOIUrl":"10.3390/ncrna12050033","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Prostate cancer (PCa) has a high incidence worldwide, yet reliable prognostic biomarkers to distinguish indolent from aggressive forms are lacking. MicroRNAs (miRNAs), a class of small non-coding RNAs, are stable molecules that play an important role in cancer development and can be detected in circulation by non-invasive methods. This study aimed to examine the influence of the cell-free (cf) miRNAs levels on PCa risk and aggressiveness using plasma samples and cell models. <b>Methods:</b> Four overexpressed miRNAs in prostate cancer tissue were selected from The Cancer Genome Atlas database: miR-25-3p, miR-92a-1-5p, miR-92a-2-5p, and miR-148a-3p. Cf-miRNA levels were validated via quantitative reverse transcription polymerase chain reaction (RT-qPCR) in plasma samples from 80 PCa patients and 40 controls in a Brazilian cohort. Clinicopathological associations were analyzed to determine prognostic value. Subsequently, functional analyses were performed using transient transfection of miR-25-3p in the LNCaP cell line, assessing proliferation, migration, invasion, and target gene regulation. <b>Results:</b> Among the miRNAs analyzed, only miR-25-3p was upregulated in the plasma of PCa patients compared to controls (<i>p</i> = 0.013). Patients with International Society of Urological Pathology (ISUP) grade ≥2 presented higher expression levels of miR-25-3p (<i>p</i> = 0.020) compared to patients with ISUP grade 1. Overexpression of miR-25-3p significantly increased cell proliferation, colony formation, migration, and invasion capacity and modulated the expression of <i>BCL2L11</i>, <i>CDH1</i>, <i>CDKN1C</i>, <i>EHZ2</i>, and <i>TP53</i> genes. <b>Conclusions:</b> miR-25-3p had an oncogenic role in PCa, showing a potential marker to assess PCa development and progression using liquid biopsy.</p>","PeriodicalId":19271,"journal":{"name":"Non-Coding RNA","volume":"12 5","pages":""},"PeriodicalIF":4.2,"publicationDate":"2026-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13600208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}